EUR RADIOL 2020 10.1007/s00330-019-06581-2
Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma
Cho1, HH; Lee, G; Lee, HY; Park, H

PLoS One 2020 10.1371/journal.pone.0231227
Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles
Yoon1, HJ; Kang, J; Park, H; Sohn, I; Lee, SH; Lee, HY

KOREAN J RADIOL 2020 10.3348/kjr.2019.0630
Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions
Lee1, G; Park, H; Bak, SH; Lee, HY

RESP RES 2020 10.1186/s12931-019-1254-0
Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer
Shin1, S; Choi, YS; Jung, JJ; Im, Y; Shin, SH; Kang, D; Cho, JH; Kim, HK; Kim, J; Zo, JI; Shim, YM; Park, K; Ahn, MJ; Ahn, YC; Lee, G; Cho, J; Lee, HY; Park, HY

J Thorac Imag. 2019 Mar;34(2):103-115.
Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer: Improvements using Radiomics.
Lee G1, Bak SH, Lee HY(corresponding author), Choi JY, Park H, Ohno Y, Nishino M, Edwin J.R. van Beek, Lee KS

J Thorac Oncol. 2019 Jun 10. pii: S1556-0864(19)30454-X. doi: 10.1016/j.jtho.2019.05.033. [Epub ahead of print]
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor
Kim Y1, Kim CH, Lee HY(co-first author), Lee SH, Kim SH, Lee S, Cha H, Hong S, Kim K, Seo SW, Sun JM, Ahn MJ, Ahn JS, Park K.

Eur Radiol. 2019 Jan 29(1):468-475.
Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma.
Kim J1, Ryu SY, Lee SH, Lee HY, Park H.

Korean J Radiol. 2019 May;20(5):854-861.
Quantitative Thoracic Magnetic Resonance Criteria for the Differentiation of Cysts from Solid Masses in the Anterior Mediastinum.
Hwang EJ1, Paek M, Yoon SH, Kim J, Lee HY, Goo JM, Kim H, Kim H, Ackman JB.

PLos One. 2019 Apr 18;14(4):e0215303.
Correction: Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis.
Bak SH1, Park HY, Nam JH, Lee HY, Lee JH, Sohn I, Chung MP.

Radiology. 2019;290:805-806.
Does Spectral CT Provide Added Diagnostic Value for Defining Malignant Pleural Disease?
Lee KS1, Lee HY.

Sci Rep. 2019 Jun 19;9(1):8730. doi: 10.1038/s41598-019-45117-y.
Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer.
Bak SH1, Park H, Sohn I, Lee SH, Ahn MJ, Lee HY(corresponding author).

Int J Cancer. 2019 Feb 26.
Improved Treatment Outcome of Pembrolizumab in Patients with Non-small Cell Lung Cancer and Chronic Obstructive Pulmonary Disease.
Shin SH11, Park HY1, Im Y1, Jung HA2, Sun JM2, Ahn JS2, Ahn MJ2, Park K2, Lee HY3, Lee SH2,4.

Expert Rev Respir Med 2019 10.1080/17476348.2020.1697853
Management of incidental pulmonary nodules: current strategies and future perspectives
Kim1, TJ; Kim, CH; Lee, HY; Chung, MJ; Shin, SH; Lee, KJ; Lee, KS

INT J CANCER 2019 10.1002/ijc.32235
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Shin1, SH; Park, HY; Im, Y; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Lee, HY; Lee, SH

J THORAC ONCOL 2019 10.1016/j.jtho.2019.05.033
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor
Kim1, Y; Kim, CH; Lee, HY; Lee, SH; Kim, HS; Lee, S; Cha, H; Hong, S; Kim, K; Seo, SW; Sun, JM; Ahn, MJ; Ahn, JS; Park, K

RESP RES 2019 10.1186/s12931-019-1087-x
Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer
Im1, Y; Park, HY; Shin, S; Shin, SH; Lee, H; Ahn, JH; Sohn, I; Cho, JH; Kim, HK; Zo, JI; Shim, YM; Lee, HY; Kim, J

MEDICINE 2019 10.1097/MD.0000000000016313
Evaluating the tumor biology of lung adenocarcinoma: A multimodal analysis
Kim1, KH; Ryu, SY; Lee, HY; Choi, JY; Kwon, OJ; Kim, HK; Shim, YM

Cancer Imaging 2019 10.1186/s40644-019-0239-z
Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer
Lee1, SH; Cho, HH; Lee, HY; Park, H

SCI REP-UK 2019 10.1038/s41598-019-45117-y
Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer
Bak1, SH; Park, H; Sohn, I; Lee, SH; Ahn, MJ; Lee, HY

KOREAN J RADIOL 2019 10.3348/kjr.2018.0699
Quantitative Thoracic Magnetic Resonance Criteria for the Differentiation of Cysts from Solid Masses in the Anterior Mediastinum
Hwang1, EJ; Paek, M; Yoon, SH; Kim, J; Lee, HY; Goo, JM; Kim, H; Kim, H; Ackman, JB

PLoS One 2019 10.1371/journal.pone.0215303
Predicting clinical outcome with phenotypic clusters using quantitative CT fibrosis and emphysema features in patients with idiopathic pulmonary fibrosis
Bak1, SH; Park, HY; Nam, JH; Lee, HY; Lee, JH; Sohn, I; Chung, MP

J THORAC IMAG 2019 10.1097/RTI.0000000000000390
Measurement Variability in Treatment Response Determination for Non-Small Cell Lung Cancer Improvements Using Radiomics
Lee1, G; Bak, SH; Lee, HY; Choi, JY; Park, H; Lee, SH; Ohno, Y; Nishino, M; van Beek, EJR; Lee, KS

RADIOLOGY 2019 10.1148/radiol.2018182768
Does Spectral CT Provide Added Diagnostic Value for Defining Malignant Pleural Disease?
Lee1, KS; Lee, HY

EUR RADIOL 2019 10.1007/s00330-018-5590-0
Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma
Kim1, J; Ryu, SY; Lee, SH; Lee, HY; Park, H

Sci Rep 2018 Jun 12;8(1):8968.
Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach
Lee SW1, Park H, Lee HY(corresponding author), Sohn I, Lee SH, Kang J, Sun JM, Ahn MJ.

Sci Rep 2018 Feb 19;8(1):3284.
Imaging genotyping of functional signaling pathways in lung squamous cell lung carcinoma using a radiomics approach.
Bak SH1, Park H, Lee HY(corresponding author), Kim Y, Kim HL, Jung SH, Kim H, Kim J, Park K.

J Thorac Dis. 2018 Jan;10(1): 388-397
Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer
Kim D1, Kim HK, Kim SH, Lee HY, Cho JH, Choi YS, Kim K, Kim J, Zo JI, Shim YM.

Sci Rep. 2018 May 16;8(1):7691.
Genomic alterations of ground-glass nodular lung adenocarcinoma
Lee H1, Joung JG, Shin HT, Kim DH, Kim Y, Kim H, Kwon OJ, Shim YM, Lee HY, Lee KS, Choi YL, Park WY, Hayes DN, Um SW.

J Pathol Transl Med. 2018 May;52(3):148-156.
Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01).
Ku BM1, Heo MH, Kim JH, Cho BC, Cho EK, Min YJ, Lee KH, Sun JM, Lee SH, Ahn JS, Park K, Kim TJ, Lee HY, Kim H, Lee KJ, Ahn MJ

AJR Am J Roentgenol. 2018 Nov;211(5):1026-1034.
Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
Kim J1, Choi SJ, Lee SH, Lee HY, Park H

PLoS One. 2018 Jul 31;13(7):e0201242.
Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults.
Yang B1, Jhun BW, Shin SH, Jeong BH, Um SW, Zo JI, Lee HY, Sohn I, Kim H, Kwon OJ, Lee K

J Thorac Oncol 2018 Aug;13(8):1106-1112.
Transient asymptomatic pulmonary opacities during osimertinib treatment and its clinical implication.
Lee H1, Lee HY(co-first author), Sun JM, Lee SH, Kim Y, Park SE, Ahn JS, Park K, Ahn MJ

J Biopharm stat. 2018;28(5):927-938.
Statistical Methods for Conditional Survival Analysis.
Jung SH1, Lee HY, Chow SC.

AJR Am J Roentgenol. 2018 Jun;210(6):1216-1225.
Morphologic Characterization of Pulmonary Nodules With Ultrashort TE MRI at 3T.
Wielp?tz MO1, Lee HY, Koyama H, Yoshikawa T, Seki S, Kishida Y, Sakai Y, Kauczor HU, Sugimura K, Ohno Y.

Oncologist 2018 Jul;23(7):806-813.
Comprehensive CT Radiomic s Analysis of Lung Adenocarcinoma for Prognostication.
Lee G1, Park H, Sohn I, See SH, Song SH, Kim H, Lee KS, Shim YM, Lee HY(corresponding author).

Nucl Med Mol Imaging 2018 Apr;52(2):91-98.
CT Radiomics in Thoracic Oncology: Technique and Clinical Applications.
Lee G1, Bak SH, Lee HY(corresponding author).

AM J ROENTGENOL 2018 10.2214/AJR.18.19507
Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics
Kim1, J; Choi, SJ; Lee, SH; Lee, HY; Park, H

J BIOPHARM STAT 2018 10.1080/10543406.2017.1405012
Statistical Methods for Conditional Survival Analysis
Jung1, SH; Lee, HY; Chow, SC

J THORAC ONCOL 2018 10.1016/j.jtho.2018.04.038
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication
Lee1, H; Lee, HY; Sun, JM; Lee, SN; Kim, Y; Park, SE; Ahn, JS; Park, K; Ahn, MJ

ONCOLOGIST 2018 10.1634/theoncologist.2017-0538
Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication
Lee1, G; Park, H; Sohn, I; Lee, SH; Song, SH; Kim, H; Lee, KS; Shim, YM; Lee, HY

PLoS One 2018 10.1371/journal.pone.0201242
Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults
Yang1, B; Jhun, BW; Shin, SH; Jeong, BH; Um, SW; Zo, JI; Lee, HY; Sohn, I; Kim, H; Kwon, OJ; Lee, K

SCI REP-UK 2018 10.1038/s41598-018-27273-9
Deciphering Clinicoradiologic Phenotype for Thymidylate Synthase Expression Status in Patients with Advanced Lung Adenocarcinoma Using a Radiomics Approach
Lee1, SW; Park, H; Lee, HY; Sohn, I; Lee, SH; Kang, J; Sun, JM; Ahn, MJ

AM J ROENTGENOL 2018 10.2214/AJR.17.18961
Morphologic Characterization of Pulmonary Nodules With Ultrashort TE MRI at 3T
Wielputz1, MO; Lee, HY; Koyama, H; Yoshikawa, T; Seki, S; Kishida, Y; Sakai, Y; Kauczor, HU; Sugimura, K; Ohno, Y

SCI REP-UK 2018 10.1038/s41598-018-25800-2
Genomic alterations of ground-glass nodular lung adenocarcinoma
Lee1, H; Joung, JG; Shin, HT; Kim, DH; Kim, Y; Kim, H; Kwon, OJ; Shim, YM; Lee, HY; Lee, KS; Choi, YL; Park, WY; Hayes, DN; Um, SW

SCI REP-UK 2018 10.1038/s41598-018-21706-1
Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach
Bak1, SH; Park, H; Lee, HY; Kim, Y; Kim, HL; Jung, SH; Kim, H; Kim, J; Park, K

Journal of thoracic disease 2018 10.21037/jtd.2017.12.38
Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer
Kim1, D; Kim, HK; Kim, SH; Lee, HY; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Shim, YM
외 다수